We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App





New Saliva-Based COVID-19 Test is Less Invasive, More Accessible and Delivers Accurate Results at Lower Cost

By HospiMedica International staff writers
Posted on 17 Mar 2021
Print article
Image: URI researcher in the lab working on COVID-19 testing developments (Photo courtesy of Patrick Luce)
Image: URI researcher in the lab working on COVID-19 testing developments (Photo courtesy of Patrick Luce)
A new non-invasive COVID-19 saliva test that increases access, is accurate, simple and cost-effective could become an important screening and surveillance tool for the SARS-CoV-2 virus.

The saliva-based COVID-19 test developed by researchers at the University of Rhode Island (Kingston, RI, USA) is less invasive than many of the traditional nasal swab tests in use, and researchers say it is sensitive, specific, and can deliver results at a lower cost. The team is also working with Thermo Fisher Scientific Inc. (Waltham, MA, USA) to validate the test and provide the necessary supply chain for distribution.

The test uses branched DNA assay technology as against the more common polymerase chain reaction (PCR) tests which receive high marks for their sensitivity, but also require extraction of the nucleic acids, access to thermocyclers and other sophisticated lab equipment not as readily available across the world. With the Rhode Island Department of Health, the team has validated the assay using standard reference materials and specimens. Based on trials conducted thus far, the test appears to have a high level of sensitivity similar to or more sensitive than other top-performing saliva tests on the market – meaning the test is better able to comparably detect the level of viral load in the sample. This is particularly helpful in gauging infectivity and possibility for spread.

The University is now launching a clinical trial this week as part of the final phase of data collection and validation in preparation for an Emergency Use Authorization submission to the US Food and Drug Administration. The trial will screen student-athletes and others who consent to take part, with the data collected to be included as part of the University’s application to the FDA. FDA approval of the test for diagnostic purposes would have far-reaching implications, both at home and abroad, in terms of increasing accessibility to testing to help manage pandemic response. The researchers believe that the COVID-19 test will be one of the few assay tests that could be made globally available.

“With minimal scientific equipment, we can not only increase our capacity in the United States but also help to put tools into the hands of people in developing countries that they can use,” said URI Professor of Biomedical and Pharmaceutical Sciences Angela Slitt who led the team.

Related Links:
University of Rhode Island
Thermo Fisher Scientific Inc.


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Fetal and Maternal Monitor
F9 Series
New
Documentation System For Blood Banks
HettInfo II

Print article

Channels

Surgical Techniques

view channel
Image: The surgical team and the Edge Multi-Port Endoscopic Surgical Robot MP1000 surgical system (Photo courtesy of Wei Zhang)

Endoscopic Surgical System Enables Remote Robot-Assisted Laparoscopic Hysterectomy

Telemedicine enables patients in remote areas to access consultations and treatments, overcoming challenges related to the uneven distribution and availability of medical resources. However, the execution... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.